Synthetic organic

InformationGSK2256098 GSK2256098 is a potent, selective, reversible, and ATP competitive FAK kinase inhibitor with apparent Ki of 0.4 nM. GSK2256098 inhibits cancer cell growth and induces apoptosis .TargetsFAK 0.4 nM(Ki)In vitroGSK2256098 has been

InformationGSK2256098 GSK2256098 is a potent, selective, reversible, and ATP competitive FAK kinase inhibitor with apparent Ki of 0.4 nM. GSK2256098 inhibits cancer cell growth and induces apoptosis .TargetsFAK 0.4 nM(Ki)In vitroGSK2256098 has been

InformationGSK2256098 GSK2256098 is a potent, selective, reversible, and ATP competitive FAK kinase inhibitor with apparent Ki of 0.4 nM. GSK2256098 inhibits cancer cell growth and induces apoptosis .TargetsFAK 0.4 nM(Ki)In vitroGSK2256098 has been

GSK2256098.

GSK2256098.

GSK2256294.

GSK2256294.

InformationGSK2292767 is a potent and selectivePI3Kδinhibitor.TargetsPI3KδIn vivoGSK2292767 is highly selective for PI3Kδ over the closely related isoforms and is active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung

InformationGSK2292767 is a potent and selectivePI3Kδinhibitor.TargetsPI3KδIn vivoGSK2292767 is highly selective for PI3Kδ over the closely related isoforms and is active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung

InformationGSK2292767 is a potent and selectivePI3Kδinhibitor.TargetsPI3KδIn vivoGSK2292767 is highly selective for PI3Kδ over the closely related isoforms and is active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung

InformationGSK2292767 is a potent and selectivePI3Kδinhibitor.TargetsPI3KδIn vivoGSK2292767 is highly selective for PI3Kδ over the closely related isoforms and is active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung

InformationGSK2292767 is a potent and selectivePI3Kδinhibitor.TargetsPI3KδIn vivoGSK2292767 is highly selective for PI3Kδ over the closely related isoforms and is active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung